secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gain Therapeutics, Inc. (GANX)
CIK:        0001819411
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001104659-25-098376
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Gain Therapeutics director Eric Richman resigns from board without disagreement; board reduced to seven
--------------------------------------------------------------------------------

- Eric Richman resigned from the Board effective October 6, 2025.
- Resignation was not due to any disagreement with company operations, policies, or practices.
- Board size reduced from eight to seven members on October 7, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819411/000110465925098376/0001104659-25-098376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819411/000110465925098376/tm2528203d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer